Companies/JP/4521

KAKEN PHARMACEUTICAL CO., LTD. · 科研製薬株式会社

Ownership & governance

Executives 5Directors 8Avg age 61Avg tenure 4.7y
Hiroyuki Horiuchi
President
Age 64Since 2020-06-25

Executives5

Hiroyuki Horiuchi
President
Age 64Since 2020-06-25
Yasuhiro Umeda
Chief Tech/Sci/R&D Officer
Age 55Since 2024-05-31
Mitsuru Watanuki
Chief Tech/Sci/R&D Officer
Age 61Since 2017-03-31
Akemi Okuyama
Corporate Officer/Principal
Age 59Since 2018-09-30
Masashi Suzudo
Investor Relations Contact
Age 63Since 2024-05-31

Board of directors8

Hiroyuki Horiuchi
Director/Board Member
Age 64Since 2016-05-31
Shoichiro Takagi
Director/Board Member
Age 65Since 2020-05-31
Masashi Suzudo
Director/Board Member
Age 63Since 2021-05-31
Yasutomo Inoue
Director/Board Member
Age 66Since 2021-05-31
Mitsuru Watanuki
Director/Board Member
Age 61Since 2023-05-31
Yasuhiro Umeda
Director/Board Member
Age 55Since 2024-05-31
Satoko Ishikawa
Director/Board Member
Age 61Since 2024-05-31
Akemi Okuyama
Director/Board Member
Age 59Since 2025-05-31

Shareholders5

NameStakeShares
KAKEN PHARMACEUTICAL CO., LTD.
13.76 %
6,071,542
Aya Nomura
4.238 %
1,870,700
Japan Agricultural Cooperatives Group
4.175 %
1,843,000
TORAY INDUSTRIES, INC.
3.754 %
1,657,000
MIZUHO FINANCIAL GROUP, INC.
3.339 %
1,474,000

Catalog · 2026-07-09

Registry officers12

NameRoleSinceShares
井 上 康 知取締役2021-06-01-
堀 内 裕 之代表取締役社長2015-07-01-
奥 山 明 美取締役2025-06-01-
小 山 雅 博監査役2022-04-01-
松 本 洋 明監査役2021-06-01-
梅 田 泰 弘取締役2024-06-01-
石 川 さ と 子取締役2012-04-01-
石 田 直 行常勤監査役2018-07-01-

Registry · as of 2026-03-31

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 4,575Range 4,000–5,600Analysts 4
4,000Mean 4,5755,600
  • Strong buy 1
  • Hold 3

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers